Skip to search formSkip to main contentSkip to account menu

imidazolium-bis(imidazole)tetrachlororuthenate(III)

Known as: HIm (RuCl4(im)2), ImH(RuIm2Cl4), trans-imidazolium-bisimidazoletetrachlororuthenate(III) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Correction for 'Cryptand-imidazolium supported total synthesis of the lasso peptide BI-32169 and its d-enantiomer' by Ming Chen… 
2019
2019
Seven supramolecular compounds comprising multivalent imidazolium macrocycles and metal halides, {[MC-IM][Ag2I4]}n (1), {[PC-IM]2… 
2019
2019
Imidazolium-benzimidazolates are readily available conjugated mesomeric betaines, whose carbenic tautomers can form C,Nimine… 
2014
2014
To increase electrochemotherapy (ECT) applicability, the effectiveness of new drugs is being tested in combination with… 
2010
2010
Amidine-type protecting groups, i.e., N,N-dimethylformamidine (dmf) and N,N-dibutylformamidine (dbf) groups, introduced into… 
2007
2007
A hydrolysis process of the anticancer drug [ImH][trans-RuCl4(Im)2] (ICR, Im=imidazole) has been investigated using density… 
2004
2004
SummaryThe activity of the newly synthesized ruthenium derivative imidazolium-bis(imidazole)tetrachlororuthenate (III) [ImH… 
1978
1978
One simple structural change in compound (I), the destruction of its symmetry by its conversion into n-propyl-2-pyridyl…